Fu EL, Wexler DJ, Cromer SJ, Bykov K, et al. SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study. BMJ 2024;385:e078483.
PMID: 38925801